Applications | Bioprocessing

Bioprocessing

Learn how metabolomics can boost bioprocessing workflow efficiency and improve product quality.

Bioprocessing

Used By

mayo clinic
merck
cleveland clinic
johns hopkins
merck
merck
applications logos

Featured Bioprocessing Resources

Bioprocessing

Metabolomics in Bioprocessing

Bioprocessing harnesses the power of living cells to create a wide range of products, from biopharmaceuticals to sustainable, biodegradable fuels, personal care products, and more. Because cells lie at the heart of bioprocessing, optimizing them is critical. However, traditional methods for monitoring these cellular factories often rely on indirect indicators (i.e., cell growth, viability) that can’t provide a clear picture of what is happening inside the cell to impact output. Therefore, engineering a robust and reproducible biological system for bioprocessing remains challenging.

By leveraging metabolomics, scientists can address these challenges by identifying subtle changes in cells and growth media that indicate stress, nutrient limitations, toxic byproducts, or the early stages of contamination. With this real-time information, researchers can intervene early to address problems and fine-tune the bioprocessing workflow, leading to more efficient workflows that yield higher quality products.

Bioprocessing

Uncover Functional, Actionable Insights with Metabolomics

Optimizing bioprocessing pipelines remains a significant challenge. Metabolon can help researchers implement improved optimization strategies through metabolomics analysis. Using both global and targeted metabolomics panels, researchers can track crucial changes in cells and growth media in real-time, facilitating early intervention and ensuring more efficient workflows.

Understanding the impact of nutrients on cell metabolism
Optimization of high-yield cell lines
Understanding and leveraging the impact of scale-up on cell metabolism

Understanding the impact of nutrients on cell metabolism

Metabolomics can help researchers understand the nutrient requirements for cells and develop improved media for optimal growth and production. In a study published in Applied and Industrial Microbiology, researchers leveraged transcriptomics and metabolomics to study the impact of different nutrient sources on the methanotroph Methylomicrobium album BG8. Because methanotrophs are an attractive microbial platform for converting alternative feedstocks into valuable products, this work makes important contributions to the development of even more sustainable bioprocessing platforms. The results uncovered several metabolic responses specific to methanol and ammonium as carbon and nitrogen sources, respectively, and serve as a valuable starting point for additional research on optimizing methanotrophs for use in bioprocessing.

Sugden S, Lazic M, Sauvageau D, et al. Transcriptomic and Metabolomic Responses to Carbon and Nitrogen Sources in Methylomicrobium album BG8. Appl Environ Microbiol. 2021;87(13):e0038521. doi: 10.1128/AEM.00385-21.

Optimization of high-yield cell lines

Metabolomics can provide critical information for assessing and optimizing production capacity of cell lines. In a study published in the Journal of Bioscience and Engineering, researchers developed a hyperosmotic resistant CHO cell line for high-yield monoclonal antibody production using bolus feeding, which is a simpler platform than fed-batch but increases osmolality to levels harmful to the cells. Using metabolomics, they showed that their new cell line preferentially generated osmolytes like sorbitol and erythritol, suggesting that these cells were better able to handle osmotic stress. These results agreed with other measures of cell growth and demonstrate that metabolomics can play an important role in the characterization of optimized cell lines.

Kamachi Y and Omasa T. Development of hyper osmotic resistant CHO host cells for enhanced antibody production. J Biosci Bioeng. 2018;125(4):470-478. doi: 10.1016/j.jbiosc.2017.11.002

Understanding and leveraging the impact of scale-up on cell metabolism

Metabolomics can aid in the scale-up of small-small fermentation processes to industrial level production, a critical step for technology transfer and commercialization. Optimizing substrate and oxygen distribution during the transition from small-scale to large-scale fermentation is critical for ensuring consistent, quality production. In a study published in Microbial Cell Factories, researchers performed real-time exometabolome analysis of S. cerevisiae cultures in bioreactors experiencing differences in dissolved oxygen, pressure set points, and added diluents during successful scale-up. This approach revealed critical metabolic and physiological changes in response to scale-induced hypoxia and demonstrated that heterogeneities in oxygen and nutrient distribution in the bioreactor are critical considerations during process scale-up.

Fu Z, Verderame TD, Leighton JM et al. Exometabolome analysis reveals hypoxia at the up-scaling of a Saccharomyces cerevisiae high-cell density fed-batch biopharmaceutical process. Microb Cell Fact. 2014;13(1):32. doi: 10.1186/1475-2859-13-32

clia logo
iso 9001 logo
cap accreditation
certifications

Metabolomics Applications for Bioprocessing

  • ECell line characterization
  • EDevelop media and feed strategies
  • EReduce variability
  • EImprove product quality
  • EEvaluate scale-up
  • ERefine growth conditions
  • EPredict cell line performance
  • EPredict product quality
  • EEnhance process monitoring
icon quotes

“Methods allowing in‐depth understanding of CHO metabolism during cultivation are essential for better control of recombinant drug production. Limited insight into the physiological state of the cell culture could be supplemented by metabolomics analysis, which is able to identify up to hundreds of different intracellular metabolites.”

Vodopivec M, Lah L, Narat M. et al.
Metabolomic profiling of CHO fed‐batch growth phases at 10, 100, and 1,000 L. Biotechnol Bioeng. 2019;116(10):2720-2729. doi: 10.1002/bit.27087

Understanding cell culture physiology with metabolomics

Bioprocess monitoring is based largely on methods that, albeit reliable for monitoring process performance, cannot provide insight into cell culture physiologic states. Understanding cell physiology at all bioreactor scales, from small to large, is critical for optimizing bioprocess development. Metabolomic analysis, which can identify hundreds to thousands of metabolites from a single sample, is a powerful tool for understanding the physiology of cell cultures used in bioprocessing. Studies have leveraged metabolomics to characterize the differences between low and high producing clones, describe cell metabolism during fed-batch, study the impact of temperature shifts on antibody glycosylation, and identify causes for process performance differences at different bioreactor scales.

bioprocessing

Figure 1. PCA of intracellular metabolome measurements. Each plotted point represents one metabolome is labeled with day of cultivation.

For example, Vodopivec M, Lah L, Narat M. et al. designed a study to evaluate the utility of metabolomics for monitoring CHO cell fed-batch cultivation across different bioreactor scales (10L, 100L, and 1,000L). Using Metabolon’s Global Discovery Panel, the researchers identified four discrete metabolite groups corresponding to fed-batch culture phase, and these groups were consistent across different bioreactor scales, regardless of variability in viable cell densities. Their work was a good first step toward demonstrating the utility of metabolomics as a means for understanding cell culture physiology in bioprocessing, and identified several important areas of improvement for future studies.

Vodopivec M, Lah L, Narat M. et al. Metabolomic profiling of CHO fed‐batch growth phases at 10, 100, and 1,000 L. Biotechnol Bioeng. 2019;116(10):2720-2729. doi: 10.1002/bit.27087

Bioprocessing Publications and Citations

Metabolon has contributed extensively to publications ranging from basic research to clinical trials.

Bioprocessing Knowledge Base

Dive deeper by viewing our case studies and webinars. Learn more about how Metabolon furthers bioprocessing research and check back for more to stay up to date on the latest developments in metabolomics in bioprocessing.

Contact Us

Talk with an expert

Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.

Corporate Headquarters

617 Davis Drive, Suite 100
Morrisville, NC 27560

Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709

+1 (919) 572-1721

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.